10.1182/blood-2016-09-742411 - BDR in newly diagnosed patients with ...

This document has been corrected

BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years

10.1182/blood-2016-09-742411

Published Online: 2017-01-26

Journal: Blood•Publisher: American Society of Hematology

Authors: Alessandra Tedeschi•Dimitra Gika•Efstathios Kastritis•Eurydiki Michalis•Giampaolo Merlini•Giovanni Palladini•Maria Gavriatopoulou•Marie-Christine Kyrtsonis•Meletios A. Dimopoulos•Pierre Morel•Pieter Sonneveld•Ramón García-Sanz•Xavier Leleu•Zafiris Kartasis

This document has been corrected

BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years

10.1182/blood-2016-09-742411

Published Online: 2017-01-26

Journal: Blood

NOW

2022-03-17•Erratum

Gavriatopoulou M, García-Sanz R, Kastritis E, et al. BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years. Blood. 2017;129(4):456-459.

10.1182/blood.2022015380

* information provided by CrossRef

2022-03-17•Erratum

10.1182/blood.2022015380

* information provided by CrossRef

2017-01-26•Published

2022-03-17•Erratum

Gavriatopoulou M, García-Sanz R, Kastritis E, et al. BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years. Blood. 2017;129(4):456-459.

10.1182/blood.2022015380

* information provided by CrossRef

This document has been corrected

BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years

10.1182/blood-2016-09-742411

Published Online: 2017-01-26

Journal: Blood•Publisher: American Society of Hematology